J7620 – Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7620
- Long description
- Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
- Short description
- Albuterol ipratrop non-comp
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
D1GDrugs Administered through DME- Added
- January 1, 2006
- Last change
- January 1, 2007 – No change
Frequently asked questions
What is HCPCS code J7620?
J7620 is a HCPCS Level II code for albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme.
Does Medicare cover J7620?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7608 – Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
- J7609 – Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
- J7610 – Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
- J7611 – Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
- J7612 – Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
- J7613 – Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
- J7614 – Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
- J7615 – Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
- J7622 – Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7624 – Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7626 – Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
- J7627 – Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
- J7628 – Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7629 – Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7631 – Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
- J7632 – Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.